JP2012521441A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521441A5 JP2012521441A5 JP2012502164A JP2012502164A JP2012521441A5 JP 2012521441 A5 JP2012521441 A5 JP 2012521441A5 JP 2012502164 A JP2012502164 A JP 2012502164A JP 2012502164 A JP2012502164 A JP 2012502164A JP 2012521441 A5 JP2012521441 A5 JP 2012521441A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated polypeptide
- pharmaceutical composition
- amino acid
- isolated
- kda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920001184 polypeptide Polymers 0.000 claims 53
- 102000004196 processed proteins & peptides Human genes 0.000 claims 53
- 108090000765 processed proteins & peptides Proteins 0.000 claims 53
- 239000008194 pharmaceutical composition Substances 0.000 claims 30
- 150000001413 amino acids Chemical class 0.000 claims 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims 16
- 241000295644 Staphylococcaceae Species 0.000 claims 10
- 241000191940 Staphylococcus Species 0.000 claims 10
- 208000015181 infectious disease Diseases 0.000 claims 10
- OEUUFNIKLCFNLN-LLVKDONJSA-N chembl432481 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC(O)=CC=2)O)=N1 OEUUFNIKLCFNLN-LLVKDONJSA-N 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- 230000037430 deletion Effects 0.000 claims 4
- 238000012217 deletion Methods 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 4
- 241000191967 Staphylococcus aureus Species 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 208000035473 Communicable disease Diseases 0.000 claims 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 2
- 238000001962 electrophoresis Methods 0.000 claims 2
- 229920002401 polyacrylamide Polymers 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21077209P | 2009-03-23 | 2009-03-23 | |
| US61/210,772 | 2009-03-23 | ||
| PCT/US2010/028326 WO2010111273A1 (en) | 2009-03-23 | 2010-03-23 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015098351A Division JP6092933B2 (ja) | 2009-03-23 | 2015-05-13 | ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012521441A JP2012521441A (ja) | 2012-09-13 |
| JP2012521441A5 true JP2012521441A5 (enExample) | 2013-05-09 |
Family
ID=42781438
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012502164A Withdrawn JP2012521441A (ja) | 2009-03-23 | 2010-03-23 | ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法 |
| JP2015098351A Active JP6092933B2 (ja) | 2009-03-23 | 2015-05-13 | ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015098351A Active JP6092933B2 (ja) | 2009-03-23 | 2015-05-13 | ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9932373B2 (enExample) |
| EP (1) | EP2411046B1 (enExample) |
| JP (2) | JP2012521441A (enExample) |
| KR (4) | KR101770321B1 (enExample) |
| CN (1) | CN105582524A (enExample) |
| AR (1) | AR075933A1 (enExample) |
| AU (1) | AU2016201992B2 (enExample) |
| BR (1) | BRPI1011856A2 (enExample) |
| CA (1) | CA2756313A1 (enExample) |
| IL (2) | IL215330A (enExample) |
| MX (1) | MX339461B (enExample) |
| NZ (2) | NZ595231A (enExample) |
| WO (1) | WO2010111273A1 (enExample) |
| ZA (1) | ZA201106959B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0607323B8 (pt) | 2005-02-14 | 2021-05-25 | Epitopix Llc | composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo |
| BRPI1011856A2 (pt) | 2009-03-23 | 2020-11-03 | Epitopix, Llc | polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso |
| AU2013202253B2 (en) * | 2009-04-14 | 2015-03-19 | Novartis Ag | Compositions for immunising against Staphylococcus aureus |
| US9724658B2 (en) * | 2011-03-28 | 2017-08-08 | Fast & Fluid Management B.V. | Method of homogenizing a liquid |
| US8753643B1 (en) | 2012-04-11 | 2014-06-17 | Life-Science Innovations, Llc | Spray dried compositions and methods of use |
| US20170023569A1 (en) * | 2014-01-10 | 2017-01-26 | University Of Rochester | Diagnostic device and method for detection of staphylococcus infection |
| CA2991907A1 (en) * | 2015-07-10 | 2017-01-19 | Douglas T. Burkhardt | Proteins and immunizing compositions containing klebsiella proteins and methods of use |
| TW201819402A (zh) | 2016-10-21 | 2018-06-01 | 加拿大商索克普拉科學與工程公司 | 對抗葡萄球菌感染之疫苗構築體及其用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981685A (en) | 1986-03-07 | 1991-01-01 | Utah State University Foundation | Bacterial extract vaccines for veterinary application |
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| US5292869A (en) | 1989-04-27 | 1994-03-08 | The Board Of Governors Of The University | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
| US5830479A (en) | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
| CA2182976C (en) | 1994-02-09 | 2011-07-12 | Daryll A. Emery | Active immunization using a siderophore receptor protein |
| US5538733A (en) | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
| US6403337B1 (en) | 1996-01-05 | 2002-06-11 | Human Genome Sciences, Inc. | Staphylococcus aureus genes and polypeptides |
| WO1997043314A2 (en) | 1996-05-16 | 1997-11-20 | The Texas A & M University System | Collagen binding protein compositions and methods of use |
| US6680195B1 (en) | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| US6692739B1 (en) | 1998-08-31 | 2004-02-17 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
| US6703025B1 (en) | 1998-08-31 | 2004-03-09 | Inhibitex, Inc. | Multicomponent vaccines |
| US6682754B2 (en) | 1999-11-24 | 2004-01-27 | Willmar Poultry Company, Inc. | Ovo delivery of an immunogen containing implant |
| EP1268774A2 (en) * | 2000-03-21 | 2003-01-02 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in prokaryotes |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| WO2002053180A2 (en) | 2001-01-03 | 2002-07-11 | Willmar Poultry Company, Inc. | Immunizing compositions and methods of use |
| AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| GB0107661D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| EP2320233A1 (en) | 2001-06-15 | 2011-05-11 | Inhibitex, Inc. | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| AU2002353764A1 (en) | 2001-06-17 | 2003-03-18 | D-Squared Biotechnologies, Inc. | Staphylococci surface-exposed immunogenic polypeptides |
| US6720160B2 (en) | 2001-10-11 | 2004-04-13 | Helica Biosystems, Inc. | Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals |
| AU2003254555A1 (en) | 2002-07-26 | 2004-02-23 | Intercell Ag | S. aureus antigene |
| BRPI0414267A (pt) | 2003-09-19 | 2006-11-21 | Epitopix Llc | polipeptìdeos de campilobacter e métodos de uso |
| WO2005103073A2 (en) | 2004-04-27 | 2005-11-03 | Intercell Ag | Td antigens |
| EP1784220B1 (en) | 2004-08-26 | 2017-12-20 | The University Of Western Ontario | Bacterial iron acquisition targets |
| CA2581746A1 (en) * | 2004-10-25 | 2006-06-08 | The University Of Western Ontario | Staphylococcus aureus isd protein-based anti-infectives |
| BRPI0607323B8 (pt) | 2005-02-14 | 2021-05-25 | Epitopix Llc | composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo |
| US8021885B2 (en) | 2006-10-11 | 2011-09-20 | Evonik Rohmax Additives Gmbh | Method for the determination of the oxidative stability of a lubricating fluid |
| BRPI1011856A2 (pt) | 2009-03-23 | 2020-11-03 | Epitopix, Llc | polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso |
-
2010
- 2010-03-23 BR BRPI1011856-0A patent/BRPI1011856A2/pt not_active Application Discontinuation
- 2010-03-23 NZ NZ595231A patent/NZ595231A/en not_active IP Right Cessation
- 2010-03-23 KR KR1020167013476A patent/KR101770321B1/ko not_active Expired - Fee Related
- 2010-03-23 CN CN201510958692.5A patent/CN105582524A/zh active Pending
- 2010-03-23 US US13/142,524 patent/US9932373B2/en active Active
- 2010-03-23 MX MX2011009949A patent/MX339461B/es active IP Right Grant
- 2010-03-23 JP JP2012502164A patent/JP2012521441A/ja not_active Withdrawn
- 2010-03-23 EP EP10756718.2A patent/EP2411046B1/en active Active
- 2010-03-23 KR KR1020167026534A patent/KR20160114744A/ko not_active Ceased
- 2010-03-23 WO PCT/US2010/028326 patent/WO2010111273A1/en not_active Ceased
- 2010-03-23 CA CA2756313A patent/CA2756313A1/en active Pending
- 2010-03-23 KR KR1020117025065A patent/KR20120005471A/ko not_active Ceased
- 2010-03-23 KR KR1020157018079A patent/KR101684292B1/ko not_active Expired - Fee Related
- 2010-03-23 NZ NZ61455710A patent/NZ614557A/en not_active IP Right Cessation
- 2010-03-25 AR ARP100100938A patent/AR075933A1/es unknown
-
2011
- 2011-09-22 IL IL215330A patent/IL215330A/en not_active IP Right Cessation
- 2011-09-22 ZA ZA2011/06959A patent/ZA201106959B/en unknown
-
2015
- 2015-05-13 JP JP2015098351A patent/JP6092933B2/ja active Active
-
2016
- 2016-03-30 AU AU2016201992A patent/AU2016201992B2/en not_active Ceased
- 2016-10-26 IL IL248523A patent/IL248523A0/en unknown
-
2018
- 2018-04-02 US US15/943,214 patent/US20180237481A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012521441A5 (enExample) | ||
| JP6866974B2 (ja) | 新規なエンドリシンポリペプチド | |
| Toledo et al. | The enolase of Borrelia burgdorferi is a plasminogen receptor released in outer membrane vesicles | |
| JP2012000112A5 (enExample) | ||
| Hamod et al. | Outer membrane protein K as a subunit vaccine against V. anguillarum | |
| EA200601603A1 (ru) | Миметические антитела glp-1 человека, композиции, способы и применения | |
| HRP20220531T1 (hr) | Varijabilni fragmenti antitijela koji se umeću i modificirane a1-a2 domene nkg2d liganda | |
| WO2009024327A3 (en) | New proteins for use in human and animal staphylococcus infections | |
| JP2020502104A5 (enExample) | ||
| MX2010008423A (es) | Tratamiento de infecciones microbianas. | |
| JP2018527405A5 (enExample) | ||
| WO2011055968A3 (en) | Kit for detecting bacterial infection comprising novel monoclonal antibodies | |
| JP2012515157A5 (enExample) | ||
| Ermert et al. | Human IgG increases virulence of Streptococcus pyogenes through complement evasion | |
| MX374403B (es) | Secuencia de endolisina kz144 modificada. | |
| EA200702532A1 (ru) | Антитела против мср-1, композиции, способы и применения | |
| NZ613923A (en) | Antibody compositions that bind polypeptides from staphylococcus aureus | |
| Zhang et al. | The identification of six novel proteins with fibronectin or collagen type I binding activity from Streptococcus suis serotype 2 | |
| CN105237630A (zh) | 鼠疫菌素和噬菌体溶菌酶融合蛋白及其编码基因与应用 | |
| JP2013521804A5 (enExample) | ||
| ATE470673T1 (de) | Impfstoffe mit lawsoniaintrazellularis- untereinheit | |
| Vaillancourt et al. | Identification and characterization of a new cell surface protein possessing factor H-binding activity in the swine pathogen and zoonotic agent Streptococcus suis | |
| JP2012522522A5 (enExample) | ||
| DE602004024423D1 (de) | Impfstoff mit lawsonia intracellularis-untereinheit | |
| Park et al. | Intranasal vaccination with outer-membrane protein of Orientia tsutsugamushi induces protective immunity against scrub typhus |